Pharmacy Newsletter : June 2021 by Pharmacy Department,
eCommons@AKU 
Pharmacy Newsletter Publications (Newsletters & Reports) 
6-2021 
Pharmacy Newsletter : June 2021 
Pharmacy Department 
Follow this and additional works at: https://ecommons.aku.edu/pharmacy_newsletter 
 Part of the Pharmacy and Pharmaceutical Sciences Commons 
Role of Pharmacist to Overcome the 
Challenges related to COVID-19 Vaccines
Dr. Faqeeha Shakeel, Pharmacist  
Grappling with 
the third wave of 
COVID-19 will not 
be easy. To overcome 
the challenges 
against this outbreak 
certain steps have 
been taken and one of the steps is inoculation of the COVID-19 vaccines to 
develop herd immunity. Vaccines are considered to be one of the most cost-
effective means of preventing illness and death from certain outbreaks just like 
COVID-19. Since, recent approvals of COVID-19 Vaccine there are a lot of 
individuals who are reluctant to get vaccinated despite the availability of safe 
and effective vaccines. As per WHO vaccine hesitancy was rated among the top 
10 threats to global health. 







as they can act as patient educator, advocate, identifier, and immunizer as well. 
Vaccine hesitancy is being influenced by 3Cs which are complacency, convenience 
and confidence. And other than that different barriers can aggravate the vaccine 
denial which are lack of awareness, insufficient or misinformation about vaccine 
and believing on myths and various misconceptions.
What pharmacist can do to overcome challenges??
•	 Find out public fear and counsel the public about safety and efficacy of 
vaccine (e.g. it’s an inactivated virus it won’t harm you) 
•	 Listen to public, acknowledge their concerns and make them feel at ease.
•	 Let public know how vaccine works and how immune system responds 
•	 Counsel public how it can prevent from outbreak, if it cannot show 100 
percent efficacy but has the ability to reduce severity of disease.
•	 Share personal experience of vaccine with them to enhance level of trust. 
 l Answer public questions and give recommendation accordingly.
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l  Availability, assessability and appeal of immunization  
 services affect vaccine acceptanceConvenience
l In terms of efficacy and safety, what is patient’s level  
 of  interest    Confidence
l Vaccine is  not considered as essential part of 
 preventive disease or to lower the risk Complacency
Approved COVID-19 vaccines in Pakistan
Sinopharm
(2 Doses; 21 
Days Apart)
Sputnik V
(2 Doses; 21 
Days Apart)
Sinovac
(2 Doses; 28 
Days Apart)
AstraZeneca
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Myths & Facts about COVID-19 Vaccine 




COVID-19 vaccine can 




recovered, I don’t need
to get vaccinated with a
COVID-19 vaccine.
COVID-19 vaccine will 
alter my DNA.
COVID-19 vaccine has 
a potential to cause 
infertility
I Can not breastfeed 
my baby after getting 
COVID-19 vaccination
Authorized and recommended COVID-19 vaccines contain 
killed viruses which cannot make you sick with COVID-19.
You should be vaccinated regardless of whether you already 
had COVID-19. That’s because experts do not yet know how 
long you are protected from getting sick again (reinfection) 
after recovering from COVID-19.
The mRNA from a COVID-19 vaccine never enters the 
nucleus of the cell. Hence, cannot alter DNA.
There is currently no evidence that COVID-19 vaccination 
causes any problems with fertility, including the development 
of the placenta and fetus.
There is currently no evidence that COVID-19 vaccination 
causes any problems with breastfeeding. Some experts prefer 
to get vaccinated so that the baby can also develop immunity 
against COVID-19.
Step 1:
Send your CNIC number to 1166.
Step 2:
Verification Code received along 
with Vaccination Date and Center.
AKUH Employees/Students:
Walk in at our designated 
vaccination center.
General Public:
Take appointment by dialing 
AKUH Helpline Number.
How to get vaccinated from AKUH? 
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Medication Loss in the Tubing while Administration
Dr. Mehreen Muzammil, Clinical Pharmacist
Every year Institute for Safe Medication Practices (ISMP) declare top 10 medication errors reported from every part 
of the world. With that, precautions to decrease the incidence of error are also suggested. The list depends on the errors 
which have serious consequences to the patient and can be prevented. One of the error identified in these top 10 error was 
“Medication loss in the tubing when administering small-volume infusions via a primary administration set”
Small volume of infusions i.e. 50ml to 100ml (of antibiotics) are administered by long administration set connected to 
patients’ vascular access. This can result in under dosing because the residual volume in administration set may not be 
administered to patient. Primary administration set will have residual volume of around 25 ml. In order to reduce the 
harm, recommendation is to administer little secondary infusion and flush the residual volume through the drip set to 
confirm that the patient received the total medication dose. 
Lack of awareness among nurses, pharmacists and prescribers reported this error globally. There is need to consider that 
remaining 25ml solution of antibiotic lead to under dosing may result in patient’s bad outcome, infection may remain 
untreated. Under dosing has clinical impact, in sepsis, patient will result in low antibiotic levels and less time with 
minimum inhibitory concentration. Same when patient being administered anti-epileptics like levetiracetam blood levels 
will be low and time to reach the effective therapeutic concentration in blood will be longer.
Reference:
Harding M, Stefka S, Bailey M, Morgan D, Anderson A. Best practice for delivering small-volume intermittent intravenous infusions. J Infus Nurs. 2020;43(1):47-52.
One Pill can kill | Advancing your knowledge of Paediatric Toxicology
Dr. Hafsah Ashfaq, Clinical Pharmacist
Children are the victims in 68% of all poisoning exposures.  Most of the reported exposures involve Toddlers (1-4 Years 
of age). Kids are curious and they keep on putting things in their mouths. Exploring what objects feel and taste like is part 
of their curiosity. It is important to be aware of the toxic potential of medications that are at home, and to keep them out 
of the reach of children. 












Na+ channel blockade, alpha 1 
blockade
Coma, Seizures, Tachycardia followed by Hypotension and 
Bradydysrhythmias
Antimalarials 20
Na+ channel blockade, direct 
retinal damage
Prolonged QRS/QT, Torsades, Hypotension, Tinnitus, 
Vision Loss, Headache, Vertigo, Seizures
Sulfonylureas 0.1 Activates insulin release Hypoglycemia, Irritability, Lethargy, Seizures and Coma
 Codeine 10 Respiratory depression Miosis, CNS Depression, Hypopnea
Class 1 Antiarrhythmics 25 Na+ channel blockade
Prolonged PR/QRS, QT (Class 1A Agents), 
Headache, Nausea/Vomiting
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The Aga Khan University Hospital, Karachi
Provide us your Valuable Feedback!
To keep the Pharmacy Newsletter of Aga Khan University Hospital (AKUH) updated we would like to take your valuable feedback. We are grateful 
to you for sparing few minutes of your precious time to complete form by below online link or form can be emailed to you as well. Just drop us an 
email with subject Newsletter Feedback. Email us at:drug.information@aku.edu 
For Formulary supplements assistance visit  http://portal.aku.edu/pharmacy/olf.asp or Call 34861504/1506
Thank you in advance for your feedback! Link: https://forms.gle/FCo9ZuE4CConzFp46
Reference:
Koda Kimble & Young’s Applied Therapeutics Tenth Edition
https://pubmed.ncbi.nlm.nih.gov/9563428/
Chronic Therapy Medications During the Perioperative Period: To 
Continue or Discontinue?
Dr. Fariha Ayaz, Pharmacist  
Long term medication therapy for chronic conditions is often necessary to maintain the patient’s physiological condition. 
The decision to withhold such therapy is made by the physician/anaesthetist guided by the pharmacist in both inpatient & 
outpatient setups whilst counselling a patient prior to surgery. This depends on the patient’s current medical condition and 
the potential for withdrawal symptoms, worsening of patient’s underlying physiological condition, drug interaction with 
aesthetic medications, perioperative hemodynamic instability or postoperative complications such as bleeding.
ADMINISTRATION OF CHRONIC MEDICATIONS PRIOR TO SURGERY
Drug Classification Discontinued/Continued Rationale/Consequences
Beta Blockers Continue in patients with ACC/AHA Class I guideline 
indications (Angina, symptomatic arrhythmia, post-
MI)
Abrupt discontinuation when on chronic 
therapy increases risk of death intraoperative & 
postoperatively.
ACEIs/ARBs Withhold 24 hours before surgery when indicated 
(Adverse post-op effects i.e. rebound hypertension & 
atrial fibrillation)
Increase risk of hypotension after induction of 
anaesthesia which is not controlled by conventional 
vasopressors (only by vasopressin).
Statins Continued. Preoperative withdrawal in patients undergoing 
major vascular surgery increases risk of MI and 
cardiovascular death postoperatively.
Diuretics Held the morning of surgery. To minimize risk of hypovolemia & electrolyte 
abnormalities.
Oral Antidiabetic Agents Held the morning of surgery and not restarted until 
food intake resumes.
To reduce risk of hypoglycaemia.
In renal dysfunction/IV contrast media: 
Metformin discontinued 24-48 hours prior to surgery.
To reduce risk of perioperative lactic acidosis.
Antiepileptic, Carbidopa/
Levodopa, Antipsychotic, 
BZDs, SSRIs, SNRIs, 
TCAs.
Continue up to and including the morning of surgery. Greater risk of withdrawal or disease decompensation 
than for perioperative complications.
Corticosteroids Continuation of normal dose (Supplemental doses 
required in Addison’s disease)
Patients generally able to increase their endogenous 
adrenal function above their baseline dose to meet 
increased demands of surgery.
